A detailed history of Vanguard Group Inc transactions in Amgen Inc stock. As of the latest transaction made, Vanguard Group Inc holds 52,382,273 shares of AMGN stock, worth $15.1 Billion. This represents 0.31% of its overall portfolio holdings.

Number of Shares
52,382,273
Previous 51,873,366 0.98%
Holding current value
$15.1 Billion
Previous $16.2 Billion 4.14%
% of portfolio
0.31%
Previous 0.32%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$309.38 - $337.38 $157 Million - $172 Million
508,907 Added 0.98%
52,382,273 $16.9 Billion
Q2 2024

Aug 13, 2024

SELL
$262.75 - $319.31 $56.5 Million - $68.6 Million
-214,844 Reduced 0.41%
51,873,366 $16.2 Billion
Q1 2024

May 10, 2024

BUY
$268.87 - $324.56 $819 Million - $988 Million
3,045,657 Added 6.21%
52,088,210 $14.8 Billion
Q4 2023

Mar 11, 2024

BUY
$255.7 - $288.46 $1.6 Million - $1.8 Million
6,242 Added 0.01%
49,042,553 $14.1 Billion
Q4 2023

Feb 14, 2024

BUY
$255.7 - $288.46 $84,381 - $95,191
330 Added 0.0%
49,036,311 $14.1 Billion
Q3 2023

Nov 14, 2023

BUY
$218.65 - $271.46 $36.2 Million - $45 Million
165,636 Added 0.34%
49,035,981 $13.2 Billion
Q2 2023

Aug 14, 2023

BUY
$214.27 - $253.37 $8.76 Million - $10.4 Million
40,885 Added 0.08%
48,870,345 $10.9 Billion
Q1 2023

Jul 14, 2023

BUY
$225.79 - $275.2 $1.4 Million - $1.71 Million
6,209 Added 0.01%
48,829,460 $11.8 Billion
Q1 2023

May 15, 2023

BUY
$225.79 - $275.2 $171 Million - $209 Million
758,112 Added 1.58%
48,823,251 $11.8 Billion
Q4 2022

Feb 10, 2023

BUY
$229.03 - $291.01 $139 Million - $176 Million
605,628 Added 1.28%
48,065,139 $12.6 Billion
Q3 2022

Nov 14, 2022

BUY
$224.46 - $253.15 $294 Million - $332 Million
1,310,894 Added 2.84%
47,459,511 $10.7 Billion
Q2 2022

Aug 12, 2022

SELL
$230.71 - $256.74 $272 Million - $303 Million
-1,180,428 Reduced 2.49%
46,148,617 $11.2 Billion
Q1 2022

May 13, 2022

BUY
$219.27 - $242.57 $146 Million - $162 Million
668,036 Added 1.43%
47,329,045 $11.4 Billion
Q4 2021

Feb 14, 2022

SELL
$198.88 - $227.6 $27.1 Million - $31 Million
-136,233 Reduced 0.29%
46,661,009 $10.5 Billion
Q3 2021

Nov 12, 2021

SELL
$212.27 - $248.7 $66.6 Million - $78 Million
-313,630 Reduced 0.67%
46,797,242 $9.95 Billion
Q2 2021

Aug 13, 2021

BUY
$233.58 - $259.14 $11 Billion - $12.2 Billion
47,110,872 New
47,110,872 $11.5 Billion

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $154B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.